Related Experiment Video
Updated: Feb 1, 2026

High Density Event-related Potential Data Acquisition in Cognitive Neuroscience
Published on: April 16, 2010
Drug Repositioning by Mining Adverse Event Data in ClinicalTrials.gov
1Advanced Analytics Hub, Eli Lilly and Company, Indianapolis, IN, USA. ewsu@lilly.com.
Abstract:
The protocol below describes an in silico method for drug repositioning (drug repurposing). The data source is ClinicalTrials.gov , which contains about a quarter of a million clinical studies. Mining such rich and clean clinical summary data could be helpful to many health-related researches. Described here is a method that utilizes serious adverse event data to identify potential new uses of drugs and dietary supplements (repositioning).
More Related Videos
Related Concept Videos
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Integration of Synaptic Events
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Schwarzschild Radius and Event Horizon
The minimum speed required to launch a projectile from the surface of an object to which it is gravitationally bound so that it eventually escapes the object’s gravitational field is called the escape velocity. The escape velocity is independent of the mass of the object. Merging the idea of escape...
How Data are Classified: Categorical Data
Data are classified based on whether they are measurable or not. Categorical data cannot be measured; instead, it can be divided into categories. For example, if Y denotes a person's party affiliation, some examples of Y include...

